Is cisplatin still the best platinum compound in non-small-cell lung cancer?

Ann Oncol. 2002 Oct;13(10):1515-7. doi: 10.1093/annonc/mdf331.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carboplatin / administration & dosage
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Cisplatin / adverse effects
  • Cisplatin / therapeutic use*
  • Disease-Free Survival
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Paclitaxel / administration & dosage
  • Quality of Life
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Carboplatin
  • Paclitaxel
  • Cisplatin